Health Care Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization Sort descending
Mar
11
2024
NIOSH Highlights 20 Years of Research on Engineering Controls for Nanotechnology Bergeson & Campbell, P.C.
Apr
24
2018
EFSA Consumer Survey about Emerging Food Safety Issues Includes Nanoparticles Bergeson & Campbell, P.C.
Jun
14
2023
Minnesota Will Require Manufacturers to Report Intentionally Added PFAS and Will Ban Intentionally Added PFAS in Certain Product Categories Beginning January 1, 2025 Bergeson & Campbell, P.C.
Jan
26
2019
NIOSH Publishes Nanotechnology Research Plan for 2018-2025 Bergeson & Campbell, P.C.
Jan
3
2024
NIOSH Reviews Past Nanotechnology Guidance and Needs for Future Research Bergeson & Campbell, P.C.
Aug
18
2019
EPA Begins Public Comment Period for Manufacturer Requests for Risk Evaluations of DIDP and DINP Bergeson & Campbell, P.C.
May
17
2024
EPA Bans Most Uses of Methylene Chloride, Requires Stronger Worker Safety Requirements for Remaining Industrial Uses Bergeson & Campbell, P.C.
May
6
2017
ACS Publishes Study Finding that Nanoparticles Can Travel from Lungs to Blood, Possibly Explaining Risks to Heart Bergeson & Campbell, P.C.
Jul
7
2017
IARC Will Convene Advisory Group in 2018/2019 to Consider Nominations Bergeson & Campbell, P.C.
Jun
24
2022
Senate Committee Holds Hearing on Implementation of TSCA Amendments Bergeson & Campbell, P.C.
Oct
14
2020
EPA Announces Expedited Pathway for Companies to Claim “Long-Lasting” Efficacy for Antiviral Products Bergeson & Campbell, P.C.
Oct
28
2020
EPA Seeks Comment on Its Interim Guidance on Residual Efficacy Claims Bergeson & Campbell, P.C.
Mar
21
2023
EUON Posts Nanopinions on Graphene Electronic Tattoos and How to Monitor the Crystal Defect Structure in Nanomaterials Bergeson & Campbell, P.C.
Jun
12
2023
HSE Recommends Restricting Hazardous Substances in Tattoo and Permanent Makeup Inks Bergeson & Campbell, P.C.
Dec
15
2018
EPA Proposes Joint Stipulation in Ellis Case Requiring EPA to Issue ESA Effects Determinations for Two Neonicotinoid Pesticides Bergeson & Campbell, P.C.
Jul
12
2023
UK REACH Amended to Extend Registration Deadlines Bergeson & Campbell, P.C.
Nov
22
2023
Global Regulatory Update for November 2023 Bergeson & Campbell, P.C.
Aug
25
2017
EPA Will Hold September Webinar on PBT Chemicals under TSCA Bergeson & Campbell, P.C.
Dec
13
2017
Ninth Circuit Will Review Two of Three TSCA Framework Rules Bergeson & Campbell, P.C.
Nov
15
2022
Coalition Petitions EPA to Require Health and Environmental Testing and Regulation of Polyvinyl Alcohol Bergeson & Campbell, P.C.
Apr
7
2016
NIOSH Publishes Nanotechnology Safety Program Guide for SMEs Bergeson & Campbell, P.C.
Oct
19
2021
ANSES Publishes Health Risk Assessment Guide for Nanomaterials in Food Bergeson & Campbell, P.C.
Jun
27
2019
China Accepting Nominations of Existing Chemical Substances to Existing Chemical Inventory Bergeson & Campbell, P.C.
Aug
3
2019
Nordic Council of Ministers Publishes Report on Applicability of GHS Classification Criteria to Nanomaterials Bergeson & Campbell, P.C.
May
18
2022
France Asks Providers to Give Updated R-Nano Declaration Numbers to Customers upon Request Bergeson & Campbell, P.C.
Mar
15
2018
NIOSH Publishes Poster Regarding Controlling Health Hazards When Working with Nanomaterials Bergeson & Campbell, P.C.
Jun
9
2018
New York Household Cleansing Product Disclosure Program Will Require Disclosure of Nano Ingredients Bergeson & Campbell, P.C.
Nov
2
2018
FDA Releases Statement On A New Plant And Animal Biotechnology Innovation Action Plan Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins